The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea
NCT01133431
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Male Volunteer
Interventions
DRUG:
CKD-501 0.5 mg tablet, Glimepiride 4 mg tablet
DRUG:
CKD-501 placebo tablet, Glimepiride 4 mg tablet
Sponsor
Chong Kun Dang Pharmaceutical